Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Synthon (Distribution Rights of Levocetirizine Tablets)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Drug distribution and selling rights under the Levocetirizine brand. The asset includes exclusive US rights to sell and distribute levocetirizine tablets, used for the treatment of indoor and outdoor allergies.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Commercial Services
Acquirer
Primary Office
  • P.O. Box 110487
  • Durham, NC 27709
  • United States

Synthon (Distribution Rights of Levocetirizine Tablets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Synthon (Distribution Rights of Levocetirizine Tablets)‘s full profile, request access.

Request full access to PitchBook

Synthon (Distribution Rights of Levocetirizine Tablets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Synthon (Distribution Rights of Levocetirizine Tablets)‘s full profile, request access.

Request full access to PitchBook